Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Knight-Swift Transportation Holdings Inc. (KNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Knight-Swift Transportation Holdings Inc. — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B), while Knight-Swift Transportation Holdings Inc. trades at $64.29 (market cap $10.59B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Knight-Swift Transportation Holdings Inc. pays a 1.23% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Knight-Swift Transportation Holdings Inc. for 1 Days on average.
| HALO | KNX | |
|---|---|---|
Market Cap | $12.58B | $10.59B |
Volume | 2,179,278 | 2,972,511 |
Sector | Health | Industrials |
52-Week High | $115.22 | $82.45 |
52-Week Low | $61.63 | $41.68 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $13.09B |
Dividend Yield | — | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Knight-Swift Transportation Holdings Inc.
Knight-Swift provides truckload, less-than-truckload, logistics, and freight management services. It operates a large transportation network across North America.
Read more on KNX →
